4//SEC Filing
Dispersyn Gerrit 4
Accession 0001209191-21-017569
CIK 0001533040other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:00 PM ET
Size
6.6 KB
Accession
0001209191-21-017569
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common stock, $0.0001 par value
2021-03-01+68,450→ 84,828 total - Purchase
Common stock, $0.0001 par value
2021-03-03$3.03/sh+2,500$7,575→ 87,328 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
- [F2]Includes shares of common stock underlying unvested restricted stock units.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001704417
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:00 PM ET
- Size
- 6.6 KB